ETF Exchange > XDNA ETF
XDNA - ETF Fact Sheet
iShares Genomics Immunology and Healthcare Index ETF - CAD
Fund Identification
Ticker
XDNA
ISIN
CA46437W1059
Main Metrics
Price
$47.68Expense Ratio
0.44%AuM
$9.54MTracking Difference
-0.98%Ratings
Trackinsight rating
★★★★★Official Investment Strategy
The ETF has been designed to provide investors with exposure to the performance of an index, selected at the discretion of BlackRock, that is composed of companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. The current index for the ETF is the NYSE FactSet Global Genomics and Immuno Biopharma Index.
XDNA's historical prices, performance, and flows
1m returns
11%
1m flows
$1M
* Net total returns
All data as of 17 July 2026
The ETF Exchange is brought to you by
With data and analysis by
See all XDNA data with a
free P&I Online account
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.
or Login
XDNA's characteristics
Manager
Manager statistics
1787 funds, $6,329.73Bn in AUM
Benchmark
NYSE FactSet Global Genomics and Immuno Biopharma NR Index - CAD
Replication method
Direct (Physical)
Asset class
Equity
Dividend policy
Distributing
XDNA's exposure
Countries
USA
59.76%
France
8.63%
Germany
7.85%
Other
23.76%
Sectors
Healthcare
100.00%
Top 5 holdings
Revolution Medicines, Inc.
7.39%
Moderna, Inc.
6.36%
Ipsen SA
4.81%
Merck & Co., Inc.
4.44%
Twist Bioscience Corp.
4.27%
Total holdings
49
Total weight of top 5
27.27%
